nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA5A—glaucoma	0.176	0.513	CbGaD
Topiramate—CA1—glaucoma	0.095	0.277	CbGaD
Topiramate—CA2—glaucoma	0.072	0.21	CbGaD
Topiramate—CA6—Diclofenamide—glaucoma	0.0145	0.0303	CbGbCtD
Topiramate—CA6—Brinzolamide—glaucoma	0.0145	0.0303	CbGbCtD
Topiramate—CA5A—Diclofenamide—glaucoma	0.0145	0.0303	CbGbCtD
Topiramate—CA5A—Brinzolamide—glaucoma	0.0145	0.0303	CbGbCtD
Topiramate—CA6—Dorzolamide—glaucoma	0.014	0.0292	CbGbCtD
Topiramate—CA5A—Dorzolamide—glaucoma	0.014	0.0292	CbGbCtD
Topiramate—CA5B—Diclofenamide—glaucoma	0.0126	0.0264	CbGbCtD
Topiramate—CA7—Brinzolamide—glaucoma	0.0126	0.0264	CbGbCtD
Topiramate—CA7—Diclofenamide—glaucoma	0.0126	0.0264	CbGbCtD
Topiramate—CA5B—Brinzolamide—glaucoma	0.0126	0.0264	CbGbCtD
Topiramate—CA5A—Methazolamide—glaucoma	0.0125	0.0261	CbGbCtD
Topiramate—CA6—Methazolamide—glaucoma	0.0125	0.0261	CbGbCtD
Topiramate—CA5B—Dorzolamide—glaucoma	0.0122	0.0255	CbGbCtD
Topiramate—CA7—Dorzolamide—glaucoma	0.0122	0.0255	CbGbCtD
Topiramate—CA5B—Methazolamide—glaucoma	0.0109	0.0227	CbGbCtD
Topiramate—CA7—Methazolamide—glaucoma	0.0109	0.0227	CbGbCtD
Topiramate—CA9—Brinzolamide—glaucoma	0.0108	0.0226	CbGbCtD
Topiramate—CA12—Brinzolamide—glaucoma	0.0108	0.0226	CbGbCtD
Topiramate—CA12—Diclofenamide—glaucoma	0.0108	0.0226	CbGbCtD
Topiramate—CA9—Diclofenamide—glaucoma	0.0108	0.0226	CbGbCtD
Topiramate—CA12—Dorzolamide—glaucoma	0.0105	0.0219	CbGbCtD
Topiramate—CA9—Dorzolamide—glaucoma	0.0105	0.0219	CbGbCtD
Topiramate—CA1—Brinzolamide—glaucoma	0.0101	0.0212	CbGbCtD
Topiramate—CA1—Diclofenamide—glaucoma	0.0101	0.0212	CbGbCtD
Topiramate—CA6—Acetazolamide—glaucoma	0.00997	0.0208	CbGbCtD
Topiramate—CA5A—Acetazolamide—glaucoma	0.00997	0.0208	CbGbCtD
Topiramate—CA1—Dorzolamide—glaucoma	0.00979	0.0205	CbGbCtD
Topiramate—CA4—Brinzolamide—glaucoma	0.00953	0.0199	CbGbCtD
Topiramate—CA4—Diclofenamide—glaucoma	0.00953	0.0199	CbGbCtD
Topiramate—CA12—Methazolamide—glaucoma	0.00933	0.0195	CbGbCtD
Topiramate—CA9—Methazolamide—glaucoma	0.00933	0.0195	CbGbCtD
Topiramate—CA4—Dorzolamide—glaucoma	0.0092	0.0192	CbGbCtD
Topiramate—CA2—Brinzolamide—glaucoma	0.00876	0.0183	CbGbCtD
Topiramate—CA2—Diclofenamide—glaucoma	0.00876	0.0183	CbGbCtD
Topiramate—CA1—Methazolamide—glaucoma	0.00872	0.0182	CbGbCtD
Topiramate—CA7—Acetazolamide—glaucoma	0.00869	0.0182	CbGbCtD
Topiramate—CA5B—Acetazolamide—glaucoma	0.00869	0.0182	CbGbCtD
Topiramate—CA2—Dorzolamide—glaucoma	0.00846	0.0177	CbGbCtD
Topiramate—CA4—Methazolamide—glaucoma	0.0082	0.0171	CbGbCtD
Topiramate—CA2—Methazolamide—glaucoma	0.00754	0.0158	CbGbCtD
Topiramate—CA9—Acetazolamide—glaucoma	0.00746	0.0156	CbGbCtD
Topiramate—CA12—Acetazolamide—glaucoma	0.00746	0.0156	CbGbCtD
Topiramate—CA1—Acetazolamide—glaucoma	0.00697	0.0146	CbGbCtD
Topiramate—CA4—Acetazolamide—glaucoma	0.00656	0.0137	CbGbCtD
Topiramate—CA2—Acetazolamide—glaucoma	0.00603	0.0126	CbGbCtD
Topiramate—CYP2C19—Methazolamide—glaucoma	0.0016	0.00335	CbGbCtD
Topiramate—CYP2C19—Timolol—glaucoma	0.00136	0.00285	CbGbCtD
Topiramate—CYP3A4—Pilocarpine—glaucoma	0.00115	0.0024	CbGbCtD
Topiramate—GRIA4—eye—glaucoma	0.000935	0.135	CbGeAlD
Topiramate—GRIA4—retina—glaucoma	0.000927	0.134	CbGeAlD
Topiramate—CYP3A4—Brinzolamide—glaucoma	0.0009	0.00188	CbGbCtD
Topiramate—CYP3A4—Dorzolamide—glaucoma	0.000869	0.00182	CbGbCtD
Topiramate—GRIK3—retina—glaucoma	0.000855	0.124	CbGeAlD
Topiramate—GRIK1—eye—glaucoma	0.00082	0.119	CbGeAlD
Topiramate—GRIK1—retina—glaucoma	0.000813	0.118	CbGeAlD
Topiramate—CYP3A4—Methazolamide—glaucoma	0.000774	0.00162	CbGbCtD
Topiramate—CYP3A4—Acetazolamide—glaucoma	0.000619	0.00129	CbGbCtD
Topiramate—CYP3A4—Clonidine—glaucoma	0.00056	0.00117	CbGbCtD
Topiramate—GRIA1—eye—glaucoma	0.000407	0.0589	CbGeAlD
Topiramate—GRIA1—retina—glaucoma	0.000403	0.0584	CbGeAlD
Topiramate—GRIK2—eye—glaucoma	0.000292	0.0423	CbGeAlD
Topiramate—GRIK2—retina—glaucoma	0.00029	0.0419	CbGeAlD
Topiramate—CA12—eye—glaucoma	0.000273	0.0395	CbGeAlD
Topiramate—CA12—connective tissue—glaucoma	0.000263	0.0381	CbGeAlD
Topiramate—CA1—eye—glaucoma	0.000216	0.0313	CbGeAlD
Topiramate—CA2—eye—glaucoma	0.00014	0.0203	CbGeAlD
Topiramate—CA2—retina—glaucoma	0.000139	0.0201	CbGeAlD
Topiramate—CA2—connective tissue—glaucoma	0.000135	0.0195	CbGeAlD
Topiramate—CA1—Metabolism—NARFL—glaucoma	4.32e-05	0.000705	CbGpPWpGaD
Topiramate—CA1—Metabolism—CA5A—glaucoma	4.32e-05	0.000705	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—PEX19—glaucoma	4.3e-05	0.000702	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CDKN2A—glaucoma	4.2e-05	0.000686	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—NTRK1—glaucoma	4.13e-05	0.000674	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—SLC6A13—glaucoma	4.11e-05	0.000671	CbGpPWpGaD
Topiramate—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	4.07e-05	0.000663	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—NCK2—glaucoma	4.03e-05	0.000657	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HDAC9—glaucoma	3.99e-05	0.000651	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—NCK2—glaucoma	3.97e-05	0.000647	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—BAD—glaucoma	3.96e-05	0.000646	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—SLC6A13—glaucoma	3.94e-05	0.000643	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—PTGS2—glaucoma	3.93e-05	0.000641	CbGpPWpGaD
Topiramate—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	3.91e-05	0.000638	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—SLC6A1—glaucoma	3.84e-05	0.000627	CbGpPWpGaD
Topiramate—CA9—Metabolism—CA5A—glaucoma	3.8e-05	0.00062	CbGpPWpGaD
Topiramate—CA9—Metabolism—NARFL—glaucoma	3.8e-05	0.00062	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—BDNF—glaucoma	3.79e-05	0.000617	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—SLC6A1—glaucoma	3.77e-05	0.000614	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—PEX19—glaucoma	3.76e-05	0.000613	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—CDKN1B—glaucoma	3.72e-05	0.000607	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—SLC6A13—glaucoma	3.61e-05	0.000588	CbGpPWpGaD
Topiramate—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	3.54e-05	0.000577	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—SLC6A1—glaucoma	3.44e-05	0.000562	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—NGF—glaucoma	3.36e-05	0.000548	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CA1—glaucoma	3.33e-05	0.000543	CbGpPWpGaD
Topiramate—CA6—Metabolism—CA1—glaucoma	3.33e-05	0.000543	CbGpPWpGaD
Topiramate—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	3.31e-05	0.000539	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.3e-05	0.000538	CbGpPWpGaD
Topiramate—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	3.25e-05	0.00053	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—BDNF—glaucoma	3.24e-05	0.000528	CbGpPWpGaD
Topiramate—CA6—Metabolism—CTSA—glaucoma	3.23e-05	0.000526	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CTSA—glaucoma	3.23e-05	0.000526	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.18e-05	0.000518	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—SLC6A13—glaucoma	3.15e-05	0.000514	CbGpPWpGaD
Topiramate—CA7—Metabolism—CA1—glaucoma	3.11e-05	0.000507	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CA1—glaucoma	3.11e-05	0.000507	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—IL1A—glaucoma	3.11e-05	0.000507	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CA2—glaucoma	3.05e-05	0.000497	CbGpPWpGaD
Topiramate—CA6—Metabolism—CA2—glaucoma	3.05e-05	0.000497	CbGpPWpGaD
Topiramate—CA7—Metabolism—CTSA—glaucoma	3.01e-05	0.000491	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CTSA—glaucoma	3.01e-05	0.000491	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—SLC6A1—glaucoma	3.01e-05	0.000491	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.91e-05	0.000474	CbGpPWpGaD
Topiramate—Palpitations—Clonidine—glaucoma	2.9e-05	0.000264	CcSEcCtD
Topiramate—Gastrointestinal disorder—Pilocarpine—glaucoma	2.9e-05	0.000264	CcSEcCtD
Topiramate—Gastrointestinal pain—Travoprost—glaucoma	2.89e-05	0.000263	CcSEcCtD
Topiramate—GABRB2—Neuronal System—SLC6A1—glaucoma	2.89e-05	0.000471	CbGpPWpGaD
Topiramate—Loss of consciousness—Clonidine—glaucoma	2.88e-05	0.000263	CcSEcCtD
Topiramate—CA12—Metabolism—CA1—glaucoma	2.88e-05	0.00047	CbGpPWpGaD
Topiramate—Feeling abnormal—Brinzolamide—glaucoma	2.88e-05	0.000262	CcSEcCtD
Topiramate—Mental disorder—Betaxolol—glaucoma	2.88e-05	0.000262	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—NGF—glaucoma	2.87e-05	0.000468	CbGpPWpGaD
Topiramate—Pain—Pilocarpine—glaucoma	2.87e-05	0.000261	CcSEcCtD
Topiramate—Constipation—Pilocarpine—glaucoma	2.87e-05	0.000261	CcSEcCtD
Topiramate—Cough—Clonidine—glaucoma	2.86e-05	0.000261	CcSEcCtD
Topiramate—Dizziness—Apraclonidine—glaucoma	2.86e-05	0.000261	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—NR3C1—glaucoma	2.86e-05	0.000466	CbGpPWpGaD
Topiramate—Erythema—Betaxolol—glaucoma	2.86e-05	0.00026	CcSEcCtD
Topiramate—Malnutrition—Betaxolol—glaucoma	2.86e-05	0.00026	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—NTRK2—glaucoma	2.86e-05	0.000466	CbGpPWpGaD
Topiramate—CA7—Metabolism—CA2—glaucoma	2.84e-05	0.000464	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CA2—glaucoma	2.84e-05	0.000464	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—NCK2—glaucoma	2.83e-05	0.000462	CbGpPWpGaD
Topiramate—Urticaria—Dorzolamide—glaucoma	2.82e-05	0.000257	CcSEcCtD
Topiramate—Epistaxis—Timolol—glaucoma	2.82e-05	0.000256	CcSEcCtD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.81e-05	0.000458	CbGpPWpGaD
Topiramate—Abdominal pain—Dorzolamide—glaucoma	2.81e-05	0.000255	CcSEcCtD
Topiramate—Body temperature increased—Dorzolamide—glaucoma	2.81e-05	0.000255	CcSEcCtD
Topiramate—Tension—Betaxolol—glaucoma	2.8e-05	0.000255	CcSEcCtD
Topiramate—Sinusitis—Timolol—glaucoma	2.8e-05	0.000255	CcSEcCtD
Topiramate—Dysgeusia—Betaxolol—glaucoma	2.8e-05	0.000255	CcSEcCtD
Topiramate—Arthralgia—Clonidine—glaucoma	2.79e-05	0.000254	CcSEcCtD
Topiramate—Chest pain—Clonidine—glaucoma	2.79e-05	0.000254	CcSEcCtD
Topiramate—Abdominal pain—Travoprost—glaucoma	2.79e-05	0.000254	CcSEcCtD
Topiramate—CA12—Metabolism—CTSA—glaucoma	2.79e-05	0.000455	CbGpPWpGaD
Topiramate—Agranulocytosis—Timolol—glaucoma	2.79e-05	0.000254	CcSEcCtD
Topiramate—Anxiety—Clonidine—glaucoma	2.78e-05	0.000253	CcSEcCtD
Topiramate—Asthenia—Acetazolamide—glaucoma	2.78e-05	0.000253	CcSEcCtD
Topiramate—Dizziness—Bimatoprost—glaucoma	2.78e-05	0.000253	CcSEcCtD
Topiramate—Nervousness—Betaxolol—glaucoma	2.78e-05	0.000253	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	2.77e-05	0.000253	CcSEcCtD
Topiramate—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.77e-05	0.000452	CbGpPWpGaD
Topiramate—Urticaria—Brinzolamide—glaucoma	2.77e-05	0.000252	CcSEcCtD
Topiramate—GRIA2—BDNF signaling pathway—BAD—glaucoma	2.77e-05	0.000452	CbGpPWpGaD
Topiramate—Feeling abnormal—Pilocarpine—glaucoma	2.76e-05	0.000252	CcSEcCtD
Topiramate—Discomfort—Clonidine—glaucoma	2.76e-05	0.000251	CcSEcCtD
Topiramate—Vomiting—Apraclonidine—glaucoma	2.75e-05	0.000251	CcSEcCtD
Topiramate—Muscle spasms—Betaxolol—glaucoma	2.75e-05	0.00025	CcSEcCtD
Topiramate—Gastrointestinal pain—Pilocarpine—glaucoma	2.74e-05	0.00025	CcSEcCtD
Topiramate—Hypersensitivity—Brimonidine—glaucoma	2.74e-05	0.000249	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—SOD1—glaucoma	2.73e-05	0.000446	CbGpPWpGaD
Topiramate—Dry mouth—Clonidine—glaucoma	2.73e-05	0.000249	CcSEcCtD
Topiramate—Bradycardia—Timolol—glaucoma	2.73e-05	0.000249	CcSEcCtD
Topiramate—Dermatitis—Apraclonidine—glaucoma	2.73e-05	0.000248	CcSEcCtD
Topiramate—Headache—Apraclonidine—glaucoma	2.71e-05	0.000247	CcSEcCtD
Topiramate—Confusional state—Clonidine—glaucoma	2.7e-05	0.000246	CcSEcCtD
Topiramate—Vision blurred—Betaxolol—glaucoma	2.69e-05	0.000245	CcSEcCtD
Topiramate—Rhinitis—Timolol—glaucoma	2.69e-05	0.000245	CcSEcCtD
Topiramate—Oedema—Clonidine—glaucoma	2.68e-05	0.000244	CcSEcCtD
Topiramate—Tremor—Betaxolol—glaucoma	2.68e-05	0.000244	CcSEcCtD
Topiramate—Hallucination—Timolol—glaucoma	2.67e-05	0.000243	CcSEcCtD
Topiramate—Asthenia—Brimonidine—glaucoma	2.67e-05	0.000243	CcSEcCtD
Topiramate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	2.66e-05	0.000434	CbGpPWpGaD
Topiramate—Infection—Clonidine—glaucoma	2.66e-05	0.000242	CcSEcCtD
Topiramate—Abdominal pain—Pilocarpine—glaucoma	2.65e-05	0.000241	CcSEcCtD
Topiramate—Body temperature increased—Pilocarpine—glaucoma	2.65e-05	0.000241	CcSEcCtD
Topiramate—Ill-defined disorder—Betaxolol—glaucoma	2.65e-05	0.000241	CcSEcCtD
Topiramate—Diarrhoea—Acetazolamide—glaucoma	2.65e-05	0.000241	CcSEcCtD
Topiramate—Rash—Bimatoprost—glaucoma	2.65e-05	0.000241	CcSEcCtD
Topiramate—Dermatitis—Bimatoprost—glaucoma	2.64e-05	0.000241	CcSEcCtD
Topiramate—Oedema peripheral—Timolol—glaucoma	2.64e-05	0.00024	CcSEcCtD
Topiramate—Anaemia—Betaxolol—glaucoma	2.64e-05	0.00024	CcSEcCtD
Topiramate—GABRG2—Neuronal System—SLC6A1—glaucoma	2.64e-05	0.00043	CbGpPWpGaD
Topiramate—CA12—Metabolism—CA2—glaucoma	2.64e-05	0.00043	CbGpPWpGaD
Topiramate—Shock—Clonidine—glaucoma	2.64e-05	0.00024	CcSEcCtD
Topiramate—Connective tissue disorder—Timolol—glaucoma	2.63e-05	0.00024	CcSEcCtD
Topiramate—Pruritus—Brimonidine—glaucoma	2.63e-05	0.000239	CcSEcCtD
Topiramate—Headache—Bimatoprost—glaucoma	2.63e-05	0.000239	CcSEcCtD
Topiramate—Nervous system disorder—Clonidine—glaucoma	2.63e-05	0.000239	CcSEcCtD
Topiramate—Thrombocytopenia—Clonidine—glaucoma	2.62e-05	0.000239	CcSEcCtD
Topiramate—Hypersensitivity—Dorzolamide—glaucoma	2.62e-05	0.000238	CcSEcCtD
Topiramate—Tachycardia—Clonidine—glaucoma	2.61e-05	0.000238	CcSEcCtD
Topiramate—SCN1A—Developmental Biology—PAX6—glaucoma	2.61e-05	0.000426	CbGpPWpGaD
Topiramate—Hypersensitivity—Travoprost—glaucoma	2.6e-05	0.000237	CcSEcCtD
Topiramate—Skin disorder—Clonidine—glaucoma	2.6e-05	0.000237	CcSEcCtD
Topiramate—Hyperhidrosis—Clonidine—glaucoma	2.59e-05	0.000236	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—CDKN2B—glaucoma	2.59e-05	0.000422	CbGpPWpGaD
Topiramate—Visual impairment—Timolol—glaucoma	2.58e-05	0.000235	CcSEcCtD
Topiramate—Malaise—Betaxolol—glaucoma	2.58e-05	0.000235	CcSEcCtD
Topiramate—Nausea—Apraclonidine—glaucoma	2.57e-05	0.000234	CcSEcCtD
Topiramate—Hypersensitivity—Brinzolamide—glaucoma	2.57e-05	0.000234	CcSEcCtD
Topiramate—Vertigo—Betaxolol—glaucoma	2.57e-05	0.000234	CcSEcCtD
Topiramate—Syncope—Betaxolol—glaucoma	2.56e-05	0.000233	CcSEcCtD
Topiramate—Dizziness—Acetazolamide—glaucoma	2.56e-05	0.000233	CcSEcCtD
Topiramate—Anorexia—Clonidine—glaucoma	2.55e-05	0.000232	CcSEcCtD
Topiramate—Asthenia—Dorzolamide—glaucoma	2.55e-05	0.000232	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.54e-05	0.000414	CbGpPWpGaD
Topiramate—Asthenia—Travoprost—glaucoma	2.54e-05	0.000231	CcSEcCtD
Topiramate—Palpitations—Betaxolol—glaucoma	2.52e-05	0.00023	CcSEcCtD
Topiramate—Pruritus—Dorzolamide—glaucoma	2.51e-05	0.000229	CcSEcCtD
Topiramate—Loss of consciousness—Betaxolol—glaucoma	2.51e-05	0.000229	CcSEcCtD
Topiramate—Eye disorder—Timolol—glaucoma	2.51e-05	0.000228	CcSEcCtD
Topiramate—Asthenia—Brinzolamide—glaucoma	2.5e-05	0.000228	CcSEcCtD
Topiramate—Hypotension—Clonidine—glaucoma	2.5e-05	0.000228	CcSEcCtD
Topiramate—Pruritus—Travoprost—glaucoma	2.5e-05	0.000228	CcSEcCtD
Topiramate—Tinnitus—Timolol—glaucoma	2.5e-05	0.000228	CcSEcCtD
Topiramate—Cough—Betaxolol—glaucoma	2.49e-05	0.000227	CcSEcCtD
Topiramate—Nausea—Bimatoprost—glaucoma	2.49e-05	0.000227	CcSEcCtD
Topiramate—Cardiac disorder—Timolol—glaucoma	2.49e-05	0.000227	CcSEcCtD
Topiramate—Hypersensitivity—Pilocarpine—glaucoma	2.47e-05	0.000225	CcSEcCtD
Topiramate—Pruritus—Brinzolamide—glaucoma	2.47e-05	0.000225	CcSEcCtD
Topiramate—CA9—Cellular responses to stress—IL1A—glaucoma	2.47e-05	0.000402	CbGpPWpGaD
Topiramate—Vomiting—Acetazolamide—glaucoma	2.46e-05	0.000224	CcSEcCtD
Topiramate—Dizziness—Brimonidine—glaucoma	2.46e-05	0.000224	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Clonidine—glaucoma	2.44e-05	0.000222	CcSEcCtD
Topiramate—Angiopathy—Timolol—glaucoma	2.43e-05	0.000221	CcSEcCtD
Topiramate—Chest pain—Betaxolol—glaucoma	2.43e-05	0.000221	CcSEcCtD
Topiramate—Myalgia—Betaxolol—glaucoma	2.43e-05	0.000221	CcSEcCtD
Topiramate—Arthralgia—Betaxolol—glaucoma	2.43e-05	0.000221	CcSEcCtD
Topiramate—Diarrhoea—Dorzolamide—glaucoma	2.43e-05	0.000221	CcSEcCtD
Topiramate—Headache—Acetazolamide—glaucoma	2.43e-05	0.000221	CcSEcCtD
Topiramate—Anxiety—Betaxolol—glaucoma	2.42e-05	0.000221	CcSEcCtD
Topiramate—Insomnia—Clonidine—glaucoma	2.42e-05	0.000221	CcSEcCtD
Topiramate—Immune system disorder—Timolol—glaucoma	2.42e-05	0.000221	CcSEcCtD
Topiramate—Diarrhoea—Travoprost—glaucoma	2.42e-05	0.00022	CcSEcCtD
Topiramate—Mediastinal disorder—Timolol—glaucoma	2.42e-05	0.00022	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	2.42e-05	0.00022	CcSEcCtD
Topiramate—Asthenia—Pilocarpine—glaucoma	2.41e-05	0.000219	CcSEcCtD
Topiramate—Paraesthesia—Clonidine—glaucoma	2.41e-05	0.000219	CcSEcCtD
Topiramate—Discomfort—Betaxolol—glaucoma	2.4e-05	0.000219	CcSEcCtD
Topiramate—Dyspnoea—Clonidine—glaucoma	2.39e-05	0.000217	CcSEcCtD
Topiramate—Diarrhoea—Brinzolamide—glaucoma	2.39e-05	0.000217	CcSEcCtD
Topiramate—Somnolence—Clonidine—glaucoma	2.38e-05	0.000217	CcSEcCtD
Topiramate—Dry mouth—Betaxolol—glaucoma	2.38e-05	0.000217	CcSEcCtD
Topiramate—Pruritus—Pilocarpine—glaucoma	2.37e-05	0.000216	CcSEcCtD
Topiramate—Alopecia—Timolol—glaucoma	2.37e-05	0.000216	CcSEcCtD
Topiramate—Confusional state—Betaxolol—glaucoma	2.35e-05	0.000214	CcSEcCtD
Topiramate—Mental disorder—Timolol—glaucoma	2.35e-05	0.000214	CcSEcCtD
Topiramate—Dizziness—Dorzolamide—glaucoma	2.35e-05	0.000214	CcSEcCtD
Topiramate—Rash—Brimonidine—glaucoma	2.34e-05	0.000213	CcSEcCtD
Topiramate—Dermatitis—Brimonidine—glaucoma	2.34e-05	0.000213	CcSEcCtD
Topiramate—Dizziness—Travoprost—glaucoma	2.34e-05	0.000213	CcSEcCtD
Topiramate—Erythema—Timolol—glaucoma	2.33e-05	0.000213	CcSEcCtD
Topiramate—Malnutrition—Timolol—glaucoma	2.33e-05	0.000213	CcSEcCtD
Topiramate—Oedema—Betaxolol—glaucoma	2.33e-05	0.000212	CcSEcCtD
Topiramate—Headache—Brimonidine—glaucoma	2.33e-05	0.000212	CcSEcCtD
Topiramate—Decreased appetite—Clonidine—glaucoma	2.33e-05	0.000212	CcSEcCtD
Topiramate—Infection—Betaxolol—glaucoma	2.32e-05	0.000211	CcSEcCtD
Topiramate—Gastrointestinal disorder—Clonidine—glaucoma	2.31e-05	0.000211	CcSEcCtD
Topiramate—Fatigue—Clonidine—glaucoma	2.31e-05	0.00021	CcSEcCtD
Topiramate—Dizziness—Brinzolamide—glaucoma	2.31e-05	0.00021	CcSEcCtD
Topiramate—GABRA1—Neuronal System—SLC6A1—glaucoma	2.31e-05	0.000376	CbGpPWpGaD
Topiramate—Nausea—Acetazolamide—glaucoma	2.3e-05	0.000209	CcSEcCtD
Topiramate—CA4—Metabolism—CA1—glaucoma	2.3e-05	0.000375	CbGpPWpGaD
Topiramate—Diarrhoea—Pilocarpine—glaucoma	2.29e-05	0.000209	CcSEcCtD
Topiramate—Shock—Betaxolol—glaucoma	2.29e-05	0.000209	CcSEcCtD
Topiramate—Tension—Timolol—glaucoma	2.29e-05	0.000209	CcSEcCtD
Topiramate—Pain—Clonidine—glaucoma	2.29e-05	0.000209	CcSEcCtD
Topiramate—Constipation—Clonidine—glaucoma	2.29e-05	0.000209	CcSEcCtD
Topiramate—Nervous system disorder—Betaxolol—glaucoma	2.29e-05	0.000208	CcSEcCtD
Topiramate—Dysgeusia—Timolol—glaucoma	2.29e-05	0.000208	CcSEcCtD
Topiramate—Thrombocytopenia—Betaxolol—glaucoma	2.28e-05	0.000208	CcSEcCtD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.28e-05	0.000371	CbGpPWpGaD
Topiramate—Tachycardia—Betaxolol—glaucoma	2.28e-05	0.000207	CcSEcCtD
Topiramate—Nervousness—Timolol—glaucoma	2.27e-05	0.000206	CcSEcCtD
Topiramate—Skin disorder—Betaxolol—glaucoma	2.26e-05	0.000206	CcSEcCtD
Topiramate—Vomiting—Dorzolamide—glaucoma	2.26e-05	0.000205	CcSEcCtD
Topiramate—Hyperhidrosis—Betaxolol—glaucoma	2.25e-05	0.000205	CcSEcCtD
Topiramate—Rash—Dorzolamide—glaucoma	2.24e-05	0.000204	CcSEcCtD
Topiramate—Dermatitis—Dorzolamide—glaucoma	2.24e-05	0.000204	CcSEcCtD
Topiramate—Rash—Travoprost—glaucoma	2.23e-05	0.000203	CcSEcCtD
Topiramate—Dermatitis—Travoprost—glaucoma	2.23e-05	0.000203	CcSEcCtD
Topiramate—CA4—Metabolism—CTSA—glaucoma	2.23e-05	0.000363	CbGpPWpGaD
Topiramate—Headache—Dorzolamide—glaucoma	2.22e-05	0.000202	CcSEcCtD
Topiramate—Anorexia—Betaxolol—glaucoma	2.22e-05	0.000202	CcSEcCtD
Topiramate—Vomiting—Brinzolamide—glaucoma	2.22e-05	0.000202	CcSEcCtD
Topiramate—Dizziness—Pilocarpine—glaucoma	2.22e-05	0.000202	CcSEcCtD
Topiramate—Headache—Travoprost—glaucoma	2.21e-05	0.000202	CcSEcCtD
Topiramate—Nausea—Brimonidine—glaucoma	2.21e-05	0.000201	CcSEcCtD
Topiramate—Feeling abnormal—Clonidine—glaucoma	2.21e-05	0.000201	CcSEcCtD
Topiramate—CA2—Metabolism—CA1—glaucoma	2.2e-05	0.000359	CbGpPWpGaD
Topiramate—Rash—Brinzolamide—glaucoma	2.2e-05	0.0002	CcSEcCtD
Topiramate—Vision blurred—Timolol—glaucoma	2.2e-05	0.0002	CcSEcCtD
Topiramate—Dermatitis—Brinzolamide—glaucoma	2.2e-05	0.0002	CcSEcCtD
Topiramate—Gastrointestinal pain—Clonidine—glaucoma	2.19e-05	0.000199	CcSEcCtD
Topiramate—Headache—Brinzolamide—glaucoma	2.19e-05	0.000199	CcSEcCtD
Topiramate—Hypotension—Betaxolol—glaucoma	2.18e-05	0.000198	CcSEcCtD
Topiramate—CA6—Metabolism—TXN—glaucoma	2.15e-05	0.00035	CbGpPWpGaD
Topiramate—CA5A—Metabolism—TXN—glaucoma	2.15e-05	0.00035	CbGpPWpGaD
Topiramate—CA2—Metabolism—CTSA—glaucoma	2.13e-05	0.000348	CbGpPWpGaD
Topiramate—Vomiting—Pilocarpine—glaucoma	2.13e-05	0.000194	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—BDNF—glaucoma	2.13e-05	0.000348	CbGpPWpGaD
Topiramate—Urticaria—Clonidine—glaucoma	2.13e-05	0.000194	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Betaxolol—glaucoma	2.12e-05	0.000193	CcSEcCtD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.12e-05	0.000346	CbGpPWpGaD
Topiramate—Body temperature increased—Clonidine—glaucoma	2.12e-05	0.000193	CcSEcCtD
Topiramate—Abdominal pain—Clonidine—glaucoma	2.12e-05	0.000193	CcSEcCtD
Topiramate—Rash—Pilocarpine—glaucoma	2.11e-05	0.000193	CcSEcCtD
Topiramate—Dermatitis—Pilocarpine—glaucoma	2.11e-05	0.000192	CcSEcCtD
Topiramate—Insomnia—Betaxolol—glaucoma	2.11e-05	0.000192	CcSEcCtD
Topiramate—Nausea—Dorzolamide—glaucoma	2.11e-05	0.000192	CcSEcCtD
Topiramate—CA4—Metabolism—CA2—glaucoma	2.1e-05	0.000343	CbGpPWpGaD
Topiramate—Headache—Pilocarpine—glaucoma	2.1e-05	0.000191	CcSEcCtD
Topiramate—Nausea—Travoprost—glaucoma	2.1e-05	0.000191	CcSEcCtD
Topiramate—Vertigo—Timolol—glaucoma	2.1e-05	0.000191	CcSEcCtD
Topiramate—Paraesthesia—Betaxolol—glaucoma	2.09e-05	0.000191	CcSEcCtD
Topiramate—Syncope—Timolol—glaucoma	2.09e-05	0.000191	CcSEcCtD
Topiramate—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	2.09e-05	0.000341	CbGpPWpGaD
Topiramate—Dyspnoea—Betaxolol—glaucoma	2.08e-05	0.000189	CcSEcCtD
Topiramate—Nausea—Brinzolamide—glaucoma	2.07e-05	0.000189	CcSEcCtD
Topiramate—Palpitations—Timolol—glaucoma	2.06e-05	0.000188	CcSEcCtD
Topiramate—Dyspepsia—Betaxolol—glaucoma	2.05e-05	0.000187	CcSEcCtD
Topiramate—Loss of consciousness—Timolol—glaucoma	2.05e-05	0.000187	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL1A—glaucoma	2.05e-05	0.000334	CbGpPWpGaD
Topiramate—CA1—Metabolism—CTSA—glaucoma	2.05e-05	0.000334	CbGpPWpGaD
Topiramate—Cough—Timolol—glaucoma	2.04e-05	0.000185	CcSEcCtD
Topiramate—Decreased appetite—Betaxolol—glaucoma	2.03e-05	0.000185	CcSEcCtD
Topiramate—Hypertension—Timolol—glaucoma	2.02e-05	0.000183	CcSEcCtD
Topiramate—Gastrointestinal disorder—Betaxolol—glaucoma	2.01e-05	0.000183	CcSEcCtD
Topiramate—Fatigue—Betaxolol—glaucoma	2.01e-05	0.000183	CcSEcCtD
Topiramate—CA7—Metabolism—TXN—glaucoma	2e-05	0.000327	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TXN—glaucoma	2e-05	0.000327	CbGpPWpGaD
Topiramate—Constipation—Betaxolol—glaucoma	1.99e-05	0.000182	CcSEcCtD
Topiramate—Pain—Betaxolol—glaucoma	1.99e-05	0.000182	CcSEcCtD
Topiramate—Nausea—Pilocarpine—glaucoma	1.99e-05	0.000181	CcSEcCtD
Topiramate—Chest pain—Timolol—glaucoma	1.99e-05	0.000181	CcSEcCtD
Topiramate—Arthralgia—Timolol—glaucoma	1.99e-05	0.000181	CcSEcCtD
Topiramate—Myalgia—Timolol—glaucoma	1.99e-05	0.000181	CcSEcCtD
Topiramate—Anxiety—Timolol—glaucoma	1.98e-05	0.00018	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	1.97e-05	0.00018	CcSEcCtD
Topiramate—Hypersensitivity—Clonidine—glaucoma	1.97e-05	0.00018	CcSEcCtD
Topiramate—Discomfort—Timolol—glaucoma	1.96e-05	0.000179	CcSEcCtD
Topiramate—Dry mouth—Timolol—glaucoma	1.94e-05	0.000177	CcSEcCtD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.94e-05	0.000316	CbGpPWpGaD
Topiramate—CA1—Metabolism—CA2—glaucoma	1.93e-05	0.000315	CbGpPWpGaD
Topiramate—Asthenia—Clonidine—glaucoma	1.92e-05	0.000175	CcSEcCtD
Topiramate—Feeling abnormal—Betaxolol—glaucoma	1.92e-05	0.000175	CcSEcCtD
Topiramate—Confusional state—Timolol—glaucoma	1.92e-05	0.000175	CcSEcCtD
Topiramate—Oedema—Timolol—glaucoma	1.9e-05	0.000173	CcSEcCtD
Topiramate—Pruritus—Clonidine—glaucoma	1.89e-05	0.000173	CcSEcCtD
Topiramate—Infection—Timolol—glaucoma	1.89e-05	0.000172	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—NGF—glaucoma	1.89e-05	0.000309	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—NR3C1—glaucoma	1.88e-05	0.000307	CbGpPWpGaD
Topiramate—Shock—Timolol—glaucoma	1.87e-05	0.000171	CcSEcCtD
Topiramate—Nervous system disorder—Timolol—glaucoma	1.87e-05	0.00017	CcSEcCtD
Topiramate—CA12—Metabolism—TXN—glaucoma	1.86e-05	0.000303	CbGpPWpGaD
Topiramate—CA9—Metabolism—CA1—glaucoma	1.86e-05	0.000303	CbGpPWpGaD
Topiramate—Urticaria—Betaxolol—glaucoma	1.85e-05	0.000169	CcSEcCtD
Topiramate—Skin disorder—Timolol—glaucoma	1.85e-05	0.000168	CcSEcCtD
Topiramate—Body temperature increased—Betaxolol—glaucoma	1.84e-05	0.000168	CcSEcCtD
Topiramate—Hyperhidrosis—Timolol—glaucoma	1.84e-05	0.000168	CcSEcCtD
Topiramate—SCN5A—Developmental Biology—PAX6—glaucoma	1.84e-05	0.000299	CbGpPWpGaD
Topiramate—Diarrhoea—Clonidine—glaucoma	1.83e-05	0.000167	CcSEcCtD
Topiramate—Anorexia—Timolol—glaucoma	1.82e-05	0.000165	CcSEcCtD
Topiramate—CA9—Metabolism—CTSA—glaucoma	1.8e-05	0.000293	CbGpPWpGaD
Topiramate—Hypotension—Timolol—glaucoma	1.78e-05	0.000162	CcSEcCtD
Topiramate—Dizziness—Clonidine—glaucoma	1.77e-05	0.000161	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Timolol—glaucoma	1.74e-05	0.000158	CcSEcCtD
Topiramate—Insomnia—Timolol—glaucoma	1.72e-05	0.000157	CcSEcCtD
Topiramate—Hypersensitivity—Betaxolol—glaucoma	1.72e-05	0.000156	CcSEcCtD
Topiramate—Paraesthesia—Timolol—glaucoma	1.71e-05	0.000156	CcSEcCtD
Topiramate—Vomiting—Clonidine—glaucoma	1.7e-05	0.000155	CcSEcCtD
Topiramate—Dyspnoea—Timolol—glaucoma	1.7e-05	0.000155	CcSEcCtD
Topiramate—CA9—Metabolism—CA2—glaucoma	1.7e-05	0.000277	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.69e-05	0.000276	CbGpPWpGaD
Topiramate—Somnolence—Timolol—glaucoma	1.69e-05	0.000154	CcSEcCtD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.69e-05	0.000276	CbGpPWpGaD
Topiramate—Rash—Clonidine—glaucoma	1.69e-05	0.000154	CcSEcCtD
Topiramate—Dermatitis—Clonidine—glaucoma	1.69e-05	0.000154	CcSEcCtD
Topiramate—Headache—Clonidine—glaucoma	1.68e-05	0.000153	CcSEcCtD
Topiramate—Dyspepsia—Timolol—glaucoma	1.68e-05	0.000153	CcSEcCtD
Topiramate—Asthenia—Betaxolol—glaucoma	1.67e-05	0.000152	CcSEcCtD
Topiramate—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.67e-05	0.000272	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTT1—glaucoma	1.66e-05	0.000271	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTT1—glaucoma	1.66e-05	0.000271	CbGpPWpGaD
Topiramate—Decreased appetite—Timolol—glaucoma	1.66e-05	0.000151	CcSEcCtD
Topiramate—Pruritus—Betaxolol—glaucoma	1.65e-05	0.00015	CcSEcCtD
Topiramate—Gastrointestinal disorder—Timolol—glaucoma	1.64e-05	0.00015	CcSEcCtD
Topiramate—Fatigue—Timolol—glaucoma	1.64e-05	0.00015	CcSEcCtD
Topiramate—Pain—Timolol—glaucoma	1.63e-05	0.000148	CcSEcCtD
Topiramate—SCN1A—Axon guidance—MMP2—glaucoma	1.61e-05	0.000263	CbGpPWpGaD
Topiramate—Diarrhoea—Betaxolol—glaucoma	1.6e-05	0.000145	CcSEcCtD
Topiramate—Nausea—Clonidine—glaucoma	1.59e-05	0.000145	CcSEcCtD
Topiramate—Feeling abnormal—Timolol—glaucoma	1.57e-05	0.000143	CcSEcCtD
Topiramate—Gastrointestinal pain—Timolol—glaucoma	1.56e-05	0.000142	CcSEcCtD
Topiramate—CA5B—Metabolism—GSTT1—glaucoma	1.55e-05	0.000253	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTT1—glaucoma	1.55e-05	0.000253	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.55e-05	0.000253	CbGpPWpGaD
Topiramate—Dizziness—Betaxolol—glaucoma	1.54e-05	0.00014	CcSEcCtD
Topiramate—CYP2C19—Biological oxidations—GSTT1—glaucoma	1.52e-05	0.000248	CbGpPWpGaD
Topiramate—Urticaria—Timolol—glaucoma	1.51e-05	0.000138	CcSEcCtD
Topiramate—Abdominal pain—Timolol—glaucoma	1.51e-05	0.000137	CcSEcCtD
Topiramate—Body temperature increased—Timolol—glaucoma	1.51e-05	0.000137	CcSEcCtD
Topiramate—Vomiting—Betaxolol—glaucoma	1.48e-05	0.000135	CcSEcCtD
Topiramate—CA4—Metabolism—TXN—glaucoma	1.48e-05	0.000241	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN2A—glaucoma	1.48e-05	0.000241	CbGpPWpGaD
Topiramate—Rash—Betaxolol—glaucoma	1.47e-05	0.000134	CcSEcCtD
Topiramate—Dermatitis—Betaxolol—glaucoma	1.47e-05	0.000134	CcSEcCtD
Topiramate—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	1.47e-05	0.000239	CbGpPWpGaD
Topiramate—Headache—Betaxolol—glaucoma	1.46e-05	0.000133	CcSEcCtD
Topiramate—CA12—Metabolism—GSTT1—glaucoma	1.44e-05	0.000235	CbGpPWpGaD
Topiramate—CA2—Metabolism—TXN—glaucoma	1.42e-05	0.000232	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.42e-05	0.000231	CbGpPWpGaD
Topiramate—Hypersensitivity—Timolol—glaucoma	1.4e-05	0.000128	CcSEcCtD
Topiramate—Nausea—Betaxolol—glaucoma	1.39e-05	0.000126	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.37e-05	0.000224	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.37e-05	0.000223	CbGpPWpGaD
Topiramate—Asthenia—Timolol—glaucoma	1.37e-05	0.000124	CcSEcCtD
Topiramate—CA1—Metabolism—TXN—glaucoma	1.36e-05	0.000222	CbGpPWpGaD
Topiramate—Pruritus—Timolol—glaucoma	1.35e-05	0.000123	CcSEcCtD
Topiramate—CA5A—Metabolism—ABCA1—glaucoma	1.33e-05	0.000216	CbGpPWpGaD
Topiramate—CA6—Metabolism—ABCA1—glaucoma	1.33e-05	0.000216	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CYP1B1—glaucoma	1.33e-05	0.000216	CbGpPWpGaD
Topiramate—CA6—Metabolism—CYP1B1—glaucoma	1.33e-05	0.000216	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—CDKN1B—glaucoma	1.31e-05	0.000214	CbGpPWpGaD
Topiramate—Diarrhoea—Timolol—glaucoma	1.3e-05	0.000119	CcSEcCtD
Topiramate—Dizziness—Timolol—glaucoma	1.26e-05	0.000115	CcSEcCtD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.24e-05	0.000202	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CYP1B1—glaucoma	1.24e-05	0.000202	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ABCA1—glaucoma	1.24e-05	0.000202	CbGpPWpGaD
Topiramate—CA7—Metabolism—ABCA1—glaucoma	1.24e-05	0.000202	CbGpPWpGaD
Topiramate—CA7—Metabolism—CYP1B1—glaucoma	1.24e-05	0.000202	CbGpPWpGaD
Topiramate—Vomiting—Timolol—glaucoma	1.21e-05	0.00011	CcSEcCtD
Topiramate—SCN1A—Axon guidance—MMP9—glaucoma	1.21e-05	0.000197	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—CYP1B1—glaucoma	1.21e-05	0.000197	CbGpPWpGaD
Topiramate—Rash—Timolol—glaucoma	1.2e-05	0.000109	CcSEcCtD
Topiramate—Dermatitis—Timolol—glaucoma	1.2e-05	0.000109	CcSEcCtD
Topiramate—CA9—Metabolism—TXN—glaucoma	1.2e-05	0.000195	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	1.19e-05	0.000195	CbGpPWpGaD
Topiramate—Headache—Timolol—glaucoma	1.19e-05	0.000109	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—TNF—glaucoma	1.18e-05	0.000192	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP2—glaucoma	1.15e-05	0.000187	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTT1—glaucoma	1.15e-05	0.000187	CbGpPWpGaD
Topiramate—CA12—Metabolism—ABCA1—glaucoma	1.15e-05	0.000187	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP1B1—glaucoma	1.15e-05	0.000187	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP2—glaucoma	1.13e-05	0.000185	CbGpPWpGaD
Topiramate—Nausea—Timolol—glaucoma	1.13e-05	0.000103	CcSEcCtD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.13e-05	0.000184	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTT1—glaucoma	1.1e-05	0.00018	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—VEGFA—glaucoma	1.09e-05	0.000178	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VEGFA—glaucoma	1.09e-05	0.000177	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NARFL—glaucoma	1.06e-05	0.000174	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA5A—glaucoma	1.06e-05	0.000174	CbGpPWpGaD
Topiramate—CA6—Metabolism—GSTM1—glaucoma	1.06e-05	0.000173	CbGpPWpGaD
Topiramate—CA5A—Metabolism—GSTM1—glaucoma	1.06e-05	0.000173	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTT1—glaucoma	1.06e-05	0.000172	CbGpPWpGaD
Topiramate—CA7—Metabolism—GSTM1—glaucoma	9.9e-06	0.000161	CbGpPWpGaD
Topiramate—CA5B—Metabolism—GSTM1—glaucoma	9.9e-06	0.000161	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—GSTM1—glaucoma	9.67e-06	0.000158	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	9.54e-06	0.000156	CbGpPWpGaD
Topiramate—CA6—Metabolism—MTHFR—glaucoma	9.37e-06	0.000153	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MTHFR—glaucoma	9.37e-06	0.000153	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTT1—glaucoma	9.28e-06	0.000151	CbGpPWpGaD
Topiramate—CA12—Metabolism—GSTM1—glaucoma	9.17e-06	0.00015	CbGpPWpGaD
Topiramate—CA4—Metabolism—ABCA1—glaucoma	9.15e-06	0.000149	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP1B1—glaucoma	9.15e-06	0.000149	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTT1—glaucoma	9.13e-06	0.000149	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—VEGFA—glaucoma	9.04e-06	0.000147	CbGpPWpGaD
Topiramate—CA2—Metabolism—ABCA1—glaucoma	8.77e-06	0.000143	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP1B1—glaucoma	8.77e-06	0.000143	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MTHFR—glaucoma	8.75e-06	0.000143	CbGpPWpGaD
Topiramate—CA7—Metabolism—MTHFR—glaucoma	8.75e-06	0.000143	CbGpPWpGaD
Topiramate—CA5A—Metabolism—APOE—glaucoma	8.72e-06	0.000142	CbGpPWpGaD
Topiramate—CA6—Metabolism—APOE—glaucoma	8.72e-06	0.000142	CbGpPWpGaD
Topiramate—CA6—Metabolism—CAV1—glaucoma	8.64e-06	0.000141	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CAV1—glaucoma	8.64e-06	0.000141	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP9—glaucoma	8.64e-06	0.000141	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP9—glaucoma	8.51e-06	0.000139	CbGpPWpGaD
Topiramate—CA1—Metabolism—ABCA1—glaucoma	8.41e-06	0.000137	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP1B1—glaucoma	8.41e-06	0.000137	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—glaucoma	8.23e-06	0.000134	CbGpPWpGaD
Topiramate—CA5B—Metabolism—APOE—glaucoma	8.14e-06	0.000133	CbGpPWpGaD
Topiramate—CA7—Metabolism—APOE—glaucoma	8.14e-06	0.000133	CbGpPWpGaD
Topiramate—CA12—Metabolism—MTHFR—glaucoma	8.1e-06	0.000132	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP2—glaucoma	8.08e-06	0.000132	CbGpPWpGaD
Topiramate—CA7—Metabolism—CAV1—glaucoma	8.07e-06	0.000132	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CAV1—glaucoma	8.07e-06	0.000132	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—glaucoma	7.76e-06	0.000127	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—glaucoma	7.75e-06	0.000126	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—glaucoma	7.64e-06	0.000125	CbGpPWpGaD
Topiramate—CA12—Metabolism—APOE—glaucoma	7.55e-06	0.000123	CbGpPWpGaD
Topiramate—CA12—Metabolism—CAV1—glaucoma	7.48e-06	0.000122	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1B1—glaucoma	7.39e-06	0.000121	CbGpPWpGaD
Topiramate—CA9—Metabolism—ABCA1—glaucoma	7.39e-06	0.000121	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTM1—glaucoma	7.31e-06	0.000119	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1B1—glaucoma	7.28e-06	0.000119	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	7.18e-06	0.000117	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTM1—glaucoma	7.01e-06	0.000114	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTM1—glaucoma	6.72e-06	0.00011	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—glaucoma	6.65e-06	0.000108	CbGpPWpGaD
Topiramate—CA5A—Metabolism—NOS3—glaucoma	6.54e-06	0.000107	CbGpPWpGaD
Topiramate—CA6—Metabolism—NOS3—glaucoma	6.54e-06	0.000107	CbGpPWpGaD
Topiramate—CA4—Metabolism—MTHFR—glaucoma	6.46e-06	0.000105	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA5A—glaucoma	6.4e-06	0.000104	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NARFL—glaucoma	6.4e-06	0.000104	CbGpPWpGaD
Topiramate—CA2—Metabolism—MTHFR—glaucoma	6.2e-06	0.000101	CbGpPWpGaD
Topiramate—CA5B—Metabolism—NOS3—glaucoma	6.1e-06	9.95e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—NOS3—glaucoma	6.1e-06	9.95e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—glaucoma	6.08e-06	9.91e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—APOE—glaucoma	6.02e-06	9.81e-05	CbGpPWpGaD
Topiramate—CA6—Metabolism—PTGS2—glaucoma	5.98e-06	9.75e-05	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PTGS2—glaucoma	5.98e-06	9.75e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—CAV1—glaucoma	5.96e-06	9.72e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—MTHFR—glaucoma	5.94e-06	9.69e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTM1—glaucoma	5.91e-06	9.64e-05	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.82e-06	9.49e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—APOE—glaucoma	5.77e-06	9.41e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.74e-06	9.36e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—CAV1—glaucoma	5.72e-06	9.32e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—NOS3—glaucoma	5.65e-06	9.22e-05	CbGpPWpGaD
Topiramate—CA7—Metabolism—PTGS2—glaucoma	5.58e-06	9.1e-05	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PTGS2—glaucoma	5.58e-06	9.1e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—APOE—glaucoma	5.53e-06	9.02e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—CAV1—glaucoma	5.48e-06	8.94e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—glaucoma	5.46e-06	8.9e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—glaucoma	5.22e-06	8.52e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA1—glaucoma	5.2e-06	8.48e-05	CbGpPWpGaD
Topiramate—CA12—Metabolism—PTGS2—glaucoma	5.17e-06	8.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CTSA—glaucoma	5.03e-06	8.21e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—APOE—glaucoma	4.86e-06	7.93e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—CAV1—glaucoma	4.82e-06	7.86e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CA2—glaucoma	4.75e-06	7.75e-05	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—glaucoma	4.68e-06	7.62e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.65e-06	7.58e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.65e-06	7.58e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—NOS3—glaucoma	4.51e-06	7.35e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—NOS3—glaucoma	4.32e-06	7.05e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—NOS3—glaucoma	4.14e-06	6.76e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—PTGS2—glaucoma	4.12e-06	6.72e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—PTGS2—glaucoma	3.95e-06	6.45e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PTGS2—glaucoma	3.79e-06	6.18e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—NOS3—glaucoma	3.64e-06	5.94e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TXN—glaucoma	3.35e-06	5.46e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PTGS2—glaucoma	3.33e-06	5.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA1—glaucoma	3.13e-06	5.1e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.06e-06	4.98e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.03e-06	4.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CTSA—glaucoma	3.03e-06	4.94e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CA2—glaucoma	2.86e-06	4.66e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTT1—glaucoma	2.6e-06	4.24e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.09e-06	3.42e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1B1—glaucoma	2.07e-06	3.37e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ABCA1—glaucoma	2.07e-06	3.37e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TXN—glaucoma	2.01e-06	3.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—glaucoma	1.65e-06	2.7e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTT1—glaucoma	1.56e-06	2.55e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—glaucoma	1.46e-06	2.38e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—APOE—glaucoma	1.36e-06	2.22e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CAV1—glaucoma	1.35e-06	2.2e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1B1—glaucoma	1.24e-06	2.03e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ABCA1—glaucoma	1.24e-06	2.03e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NOS3—glaucoma	1.02e-06	1.66e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—glaucoma	9.95e-07	1.62e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PTGS2—glaucoma	9.33e-07	1.52e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—glaucoma	8.79e-07	1.43e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—APOE—glaucoma	8.18e-07	1.33e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CAV1—glaucoma	8.11e-07	1.32e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NOS3—glaucoma	6.13e-07	1e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PTGS2—glaucoma	5.61e-07	9.15e-06	CbGpPWpGaD
